Related references
Note: Only part of the references are listed.PDGFReceptor Signaling in Osteoblast Lineage Cells Controls Bone Resorption Through Upregulation ofCsf1Expression
Julia Brun et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Current treatment options for HCC: from pharmacokinetics to efficacy and adverse events in liver cirrhosis.
Giovanni Galati et al.
CURRENT DRUG METABOLISM (2020)
New frontiers in the medical management of gastrointestinal stromal tumours
Alessandro Mazzocca et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Osteoporosis and sarcopenia: two diseases or one?
Jean-Yves Reginster et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2016)
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
Frederick Moryoussef et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
O. Huillard et al.
BRITISH JOURNAL OF CANCER (2013)
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
N. Harimoto et al.
BRITISH JOURNAL OF SURGERY (2013)
Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects
Kate Vandyke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia
Daniela Hoehn et al.
HUMAN PATHOLOGY (2012)
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
Heikki Joensuu et al.
LANCET ONCOLOGY (2012)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
Carla M. M. Prado et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Dysregulation of bone remodeling by imatinib mesylate
Kate Vandyke et al.
BLOOD (2010)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms
Susannah O'Sullivan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism
Andrew Grey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)
Wataru Ando et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2006)
Altered bone and mineral metabolism in patients receiving imatinib mesylate
E Berman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance
JR Taylor et al.
ONCOGENE (2006)
Gastrointestinal stromal tumors:: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era -: A population-based study in western Sweden
B Nilsson et al.
CANCER (2005)
Clinical pharmacokinetics of imatinib
B Peng et al.
CLINICAL PHARMACOKINETICS (2005)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)